Grant Yonehiro insider trades: Bolt Biotherapeutics (BOLT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Grant reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | BOLT | ↓ Sell | 13,176 | $3.32 | $44K | Direct | Sep 21, 2026 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BOLT insiders
Open-market trades in the last 12 months
About Grant Yonehiro's insider trades
Grant Yonehiro is Chief Operating Officer at Bolt Biotherapeutics (BOLT). Since Sep 18, 2026, Grant has reported no open-market purchases and 1 sale worth $44K on SEC Form 4. In the last 12 months: 1 sale ($44K).
Their filings also include grants and awards (16 filings), shares withheld for taxes (3 filings), shares returned to the company (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BOLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.